AssetID: 54739512
Headline: Weight Loss Injections Could Halve Risk of Obesity-Related Cancers, Study Finds
Caption: New research suggests that weight loss injections, specifically GLP-1 receptor agonists, may not only aid in slimming down but also significantly reduce the risk of obesity-related cancers. Obesity is the second leading cause of cancer in the UK, responsible for more than one in 20 cancer cases, according to the NHS.
Keywords: Health & Wellbeing,weight loss injections,GLP-1 receptor agonists,obesity-related cancer,bariatric surgery,NHS,cancer prevention,metabolic health,anti-cancer drugs,healthcare,pharmaceutical treatments,type 2 diabetes,European Congress on Obesity,Wegovy,weight loss,healthcare research,diabetes treatment,obesity,GLP-1,medication,health studies,pharmaceutical innovations
PersonInImage: